Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cinchocaine poisoning |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental cinchocaine poisoning |
Causative agent (attribute) |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Intentional cinchocaine poisoning |
Causative agent (attribute) |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
intoxication par la cinchocaïne d'intention indéterminée |
Causative agent (attribute) |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine adverse reaction |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to dibucaine |
Causative agent (attribute) |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Cinchocaine overdose |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Accidental cinchocaine overdose |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Intentional cinchocaine overdose |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
surdose de cinchocaïne d'intention indéterminée |
Causative agent (attribute) |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Product containing cinchocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely cinchocaine 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Prednisolone hexanoate 1.3mg / Cinchocaine 1mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Accidental cinchocaine poisoning |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Intentional cinchocaine poisoning |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing cinchocaine and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing cinchocaine and prednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing cinchocaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Cinchocaine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Serum dibucaine number (procedure) |
Component |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Dibucaine number |
Component |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Allergy to dibucaine |
Causative agent (attribute) |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine hydrochloride |
Is a |
False |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Cinchocaine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
|
Product containing cinchocaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine and prednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only cinchocaine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine 10 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Cinchocaine 10 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cinchocaine 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cinchocaine 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Cinchocaine- and prednisolone-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
2 |
Serum dibucaine number (procedure) |
Component |
True |
Cinchocaine (substance) |
Inferred relationship |
Some |
1 |